“Women are not small men,” said Jeanine Roeters van Lennep, of the Erasmus Medical Centre in Rotterdam, who is leading the project. A lack of female participants in clinical trials and a failure to report separate results by gender could lead to drugs being marketed that are less effective for women, a study has warned. The study, published on Monday in the journal JAMA, found women were more likely than men to be prescribed antidepressants with higher risk of suicidal thoughts or behaviour compared with placebos. Separate US research found that eight out of 10 drugs withdrawn from use after approval had higher risks for women.
A lack of female participants in clinical trials and a failure to report separate results by gender could lead to drugs being marketed that are less effective for women, a study has warned. The study, published on Monday in the journal JAMA, found women were more likely than men to be prescribed antidepressants with higher risk of suicidal thoughts or behaviour compared with placebos. Separate US research found that eight out of 10 drugs withdrawn from use after approval had higher risks for women.